These heteroreceptor complexes may become new targets for treatment of cocaine addiction, involving receptor interface, interfering peptides and hetero-bivalent compounds that can remove the brake on D2R protomer signaling in the A2AR-D2R-Sigma1R complexes. This evidence concerns the gene ADORA2A and cocaine dependence.